Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 2, 1998, Pages 844-852

  Lipson, Kenneth E ^a   Pang, Long ^a   Julie Huber, L ^b   Chen, Hui ^a   Tsai, Jian Ming ^a   Hirth, Peter ^a   Gazit, Aviv ^c   Levitzki, Alexander ^c   McMahon, Gerald ^a  

^a SUGEN INC   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 6,7 DIMETHOXY 2 PHENYLQUINOXALINE; BROXURIDINE; CYCLIN DEPENDENT KINASE; CYCLIN E; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NITRILES; PHOSPHORYLATION; QUINOXALINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; TYROSINE; TYRPHOSTINS;

EID: 0031809015     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 16:4327-4336.
2. Barker AJ (1993) European Patent Application EP 0 566 226.
3. Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A and vanBergen en Henegouwen P (1995) The epidermal growth factor. Cell Biol Int 19:413-430.
4. Burgaud JL and Baserga R (1996) Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Exp Cell Res 223:412-419.
5. Carpenter CL, Auger KR, Chanudhuri M, Yoakim M, Schaffhausen B, Shoelson S and Cantley LM (1993) Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem 268:9478-9483.
6. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023-32026.
7. Clemmons DR, Van Wyk JJ and Pledger WJ (1980) Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle. Proc Natl Acad Sci USA 77:6644-6648.
8. kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
9. Cohen GB, Ren R and Baltimore D (1995) Modular binding domains in signal transaction. Cell 80:237-248.
10. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R and Baserga R (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14:4588-4595.
11. DeAngelis T, Ferber A and Baserga R (1995) Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol 164:214-221.
12. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063-1070.
13. Fantl WJ, Escobedo JA, Martin GA, furck CW, del Rosario M, McCormick F and Williams LT (1992) Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69: 413-423.
14. Fedi P, Pierce JH, DiFiore PP and Kraus MH (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phopholipase Cγ or GTPase-activating protein, distinguishes ErbB3 signaling from that of other ErbB/EGFR family members. Mol Cell Biol 14:492-500.
15. Gazit A, App H, McMahon G, Chen J, Levitzki A and Bohmer FD (1996) Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: Structure-activity relationships in quinoxalines, quinolines and indole tyrphostins. J Med Chem 39:2170-2177.
16. Hu P, Margolis B, Skolnik EY, Lammers R, Ullrich A and Schlessinger J (1992) Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol 12:981-990.
17. Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley L and Roberts TM (1987) Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021-1029.
18. Kavanaugh WM, Turck CW and Williams LT (1995) PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268: 1177-1179.
19. Kazlauskas A and Cooper JA (1989) Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58:1121-1133.
20. Klippel A, Escobedo JA, Fantl WJ and Williams LT (1992) The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor. Mol Cell Biol 12:1451-1459.
21. Kovalenko M, Gazit A, Böhmer A, Rorsman C, Rönnstrand L, Heldin C-H, Waltenberger J, Böhmer F-D and Levitzki A (1994) Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6106-6114.
22. Kovalenko M, Ronnstrand L, Heldin C-H, Loubtchenkov M, Gazit A, Levitzki A and Bohmer F-D (1997) Phosphorylation site-specific inhibition of platelet-derived growth factor receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry, 36:6260-6269, 1997.
23. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
24. Levitzki A and Gazit A (1995) Tyrosine kinase inhibition: An approach to drug development. Science 267:1782-1788.
25. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D and Schlessinger J (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
26. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134.
27. Ohmichi M, Decker SJ and Saltiel AR (1992) Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with S/T homology 2 domains. Neuron 9:769-777.
28. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M (1995) Human cyclin F., a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624.
29. Osherov N and Levitzki A (1994) Epidermal-growth-factor-dependent activation of the Src-family kinases. Eur J Biochem 225:1047-1053.
30. Pang L, Decker SJ and Saltiel AR (1992) Bombesin and epidermal growth factor stimulate the mitogen activated protein kinase through different pathways in Swiss 3T3 cells. Biochem J 289:283-287.
31. Pawson T (1995) Protein modules and signaling networks. Nature 373:573-580.
32. Peles E, Lamprecht R, Ben LR, Tzahar E and Yarden Y (1992) Regulated coupling of the Neu receptor to phosphatidylinositol 3′-kinase and its release by oncogenic activation. J Biol Chem 267:12266-12274.
33. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T and Pelicci PG (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
34. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
35. Raffioni S and Bradshaw RA (1992) Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor and nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci USA 89:9121-9125.
36. Rani CSS, Wang F, Vuior E, Berger A, Wu J, Sturgill TW, Beitner-Johnson D, LeRoith D, Varticovski L and Spiegel S (1997) Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. J Biol Chem 272:10777-10783.
37. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A., Thomas S, Brugge J, Pelicci PG, Schelssinger J and Pawson T (1992) Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
38. Seedorf K (1995) Intracellular signaling by growth factors. Metabolism 10(Suppl 4):24-32.
39. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R (1996) Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Oncogene 12:1679-1687.
40. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059-1065.
41. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, Ren R, Baltimore D, Ratnofsky S, Feldman RA and Cantley LC (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB2, HCP, SHC, Syk and Vav. Mol Cell Biol 14:2777-2785.
42. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer B-J and Cantley LC (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 373:536-539.
43. Songyang Z and Cantley LC (1995) Recognition and specificity in protein tyrosine kinase-mediated signaling. Trends Biochem Sci 20:470-475.
44. Stiles CD, Capone GT, Sherr CJ, Antoniades HN, Van Wyk JJ and Pledger WJ (1979) Dual control of cell growth, by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279-1283.
45. Ullrich A and Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
46. Valius M and Kazlauskas A (1993) Phospholipase C-γl and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73:321-334.
47. van der Geer P and Hunter T (1993) Mutation of Tyr 697, a GRB2-binding site, and Tyr 721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor in rat-2 fibroblasts. EMBO J 12:5161-5172.
48. van der Geer P, Hunter T and Lindberg RA (1994) Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10:251-337.
49. kip1 by platelet-derived growth factor and plasma factors in density arrested fibroblasts. J Biol Chem 271:11253-11260.
50. Yokote K, Mori S, Hansen K, McGlade J, Pawson T, Heldin C-H and Claesson-Welsh L (1994) Direct interaction between She and the platelet-derived growth factor β-receptor. J Biol Chem 269:15337-15343.